NSN NSN Parts NSN 6505014753038

NSN 6505-01-475-3038, 6505014753038 Hepatitis B Virus Vaccine Inacti Parts Sourcing

If you have been looking for Merck Sharp And Dohme Corp parts listed alongside the NSN 6505014753038, ASAP Distribution has you covered with our unmatched inventory of items Hepatitis B Virus Vaccine Inacti. With over 2 billion parts readily available for purchase on our website, customers can get competitive pricing offers and rapid lead-times on top NSN part numbers such as NDC00006-4981-00. Explore our NSN parts catalog at your leisure, or you may take advantage of our provided search engine to find specific parts in a matter of moments. If you are interested in this particular component or others listed across our website, you may begin the procurement process at any time through the submission of an Instant RFQ form. Using the information that you submit to us, our team of industry experts will quickly craft you a quote that accommodates your individual needs and requirements for NSN 6505014753038.

Alternative NSN: 6505-01-475-3038 Item Name : Hepatitis B Virus Vaccine Inacti NIIN: 014753038 NCB Code: USA (01)

Part Number's List for NSN 6505-01-475-3038, 6505014753038

Part No Manufacturer Item Name QTY RFQ
NDC00006-4981-00 Merck Sharp And Dohme Corp hepatitis b virus vaccine inacti Avl RFQ

Characteristics Data of NSN 6505014753038

MRCCriteriaCharacteristic
AGXZUNIT PACKAGE TYPEPACKAGE
AJCNPROTECTIVE STORAGE FEATUREREQUIRES REFRIGERATION BETWEEN 2 DEG TO 8 DEG C AND SUBJECT TO DAMAGE BY FREEZING
ANNWIII IMMEDIATE CONTAINER TYPEVIAL, SINGLE DOSE
ANNXIMMEDIATE CONTAINER QUANTITY10
ANNYQUANTITY WITHIN EACH IMMEDIATE CONTAINER10DOSES AND 5MCG/0.5ML VIALS
CXCYPART NAME ASSIGNED BY CONTROLLING AGENCYHEPATITIS B VIRUS VACCINE INACTIVATED MODIFIED SGL DOSE VIAL 10S
FEATSPECIAL FEATURESVACCINE PRESERVATIVE FREE AND THIMEROSAL FREE;RECOMBIVAX HB (RECOMBINANT) IS FOR INTRAMUSCULAR INJECTION; FOR USE IN INFANTS, CHILDREN AND ADOLESCENTS (AGES 0-19); DOSAGE SUPPLIED AS 5 MCG/0.5 ML OF HBSAG (SURFACE ANTIGEN) IN A 0.5 ML SINGL
SUPPSUPPLEMENTARY FEATURESARECOMMENDED VACCINATION REGIMENS CONSISTS OF 3 DOSES AT 5MCG EACH; TO BE ADMINISTERED AS FOLLOWS: FIRST DOSE AT ELECTED DATE; SECOND DOSE 1 MONTH LATER; THIRD DOSE 6 MONTHS AFTER THE FIRST DOSE
INSTANT RFQ